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Abstract
Objective: To investigate the association between diet quality and chronic axo-
nal polyneuropathy. Methods: Between June 2013 and January 2017, among
1650 participants of the Rotterdam Study (median age 69.1 years, 54.2%
women), diet quality was quantified based on food frequency questionnaires as
a sum score of adherence (yes/no) to 14 components of the Dutch dietary
guidelines. Presence of polyneuropathy was determined based on a question-
naire, neurological examination of the legs, and nerve conduction studies. We
used logistic regression to associate diet quality with the presence of chronic
axonal polyneuropathy and linear regression to associate with sural sensory
nerve action potential (SNAP) amplitude in participants without polyneuropa-
thy. Results were adjusted for age, sex, time between measurements, body mass
index, blood pressure, diabetes mellitus, smoking, kidney function, and educa-
tion. Results: Overall diet quality was not associated with chronic axonal
polyneuropathy (odds ratio [OR] = 0.99, 95% confidence interval [CI] 0.88;
1.12, P = 0.842), nor with sural SNAP amplitude in participants without
polyneuropathy (difference = 0.01, 95% CI 0.14; 0.15, P = 0.993). Although
not surviving multiple testing, a nominally significant association was found
between salt intake ≤6 g/day and presence of chronic axonal polyneuropathy
(OR = 0.55, 95% CI 0.35; 0.86, P = 0.008). Interpretation: We did not find an
association between diet quality and chronic axonal polyneuropathy.
INTRODUCTION
Chronic axonal polyneuropathy is the most common
form of polyneuropathy. It is characterized by symmetri-
cal sensory symptoms and predominant distal weakness.
Even before clinical symptoms or signs occur, peripheral
nerve dysfunction can be quantified through nerve con-
duction studies (NCS).1 The most common risk factors in
high-income countries are diabetes mellitus, deficiencies
of vitamins B1 and B12, alcohol overuse, and metabolic
syndrome.2–4 Yet, one-third of the patients suffer from
chronic axonal polyneuropathy in the absence of known
risk factors, usually referred to as chronic idiopathic axo-
nal polyneuropathy (CIAP).5 This suggests that additional
risk factors remain to be identified.
Diet is an important determinant of health and has
been recognized as modifiable risk factor for various
chronic diseases, including cardiovascular disease, cancer,
dementia and diabetes mellitus.6–9 Diet has also been
linked to several known risk factors of polyneuropathy,
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including insulin resistance, obesity, and other compo-
nents of metabolic syndrome.10 However, data on the
association between diet and polyneuropathy are scarce.
The single study on this topic, a case–control design,
failed to find a link between intake of specific nutrients
and CIAP.11 Moreover, given the complexities of studying
individual nutrients, it may be more meaningful to study
dietary patterns, especially since such patterns can be
judged against existing guidelines and are potentially
amenable.
Therefore, we investigated the association of diet qual-
ity, based on adherence to dietary guidelines, with the
presence of chronic axonal polyneuropathy and with
peripheral nerve damage as measured with sensory NCS
in participants without polyneuropathy.
METHODS
Setting and study population
This study was part of the Rotterdam Study, an on-going
prospective population-based cohort study to investigate
chronic diseases in the older population (age ≥45 years).12
The cohort started in January 1990 (RS-I) and was
extended in 2000 (RS-II) and 2006 (RS-III). Follow-up
examinations took place every 3–5 years. Since June 2013
a polyneuropathy screening was implemented. From this
moment until January 2017, 2069 participants of subco-
horts RS-I, RS-II, and RS-III were screened for polyneu-
ropathy. From this group, 151 persons were excluded due
to insufficient screening. Of the 1918 remaining partici-
pants, dietary data were present for 1650 participants.
Sural sensory nerve action potential (SNAP) amplitude
and dietary data were available in 1272 participants of
which 70 participants had definite polyneuropathy. We
investigated subclinical nerve damage by analyzing the
sural SNAP amplitude in participants without definite
polyneuropathy (N = 1202).
Standard protocol approvals, registrations
and patients consents
The Rotterdam Study has been approved by the Medical
Ethics Committee of Erasmus MC (registration number
MEC 02.1015) and by the Dutch Ministry of Health, Wel-
fare and Sport (Population Screening Act WBO, license
number 1071272-159521-PG). The Rotterdam Study Per-
sonal Registration Data collection is filed with the Eras-
mus MC Data Protection Officer under registration
number EMC1712001. The Rotterdam Study has been
entered into the Netherlands National Trial Register and
into the WHO International Clinical Trials Registry Plat-
form under shared catalogue number NTR6831. All
participants provided written informed consent to partici-
pate in the study and to have their information obtained
from treating physicians.
Assessment of diet quality and intake
Diet quality was assessed using a 389-item validated food
frequency questionnaires (FFQ) as described elsewhere.13
Nutrient data were calculated using the Dutch Food
Composition Table. For the current analyses, we used
dietary data collected in subcohort RS-I, RS-II, and RS-III
at examination round 5, 3, and 1 respectively. Median
time difference between assessment of dietary habits and
polyneuropathy screening was 5.1 years (range 3.7–
8.2 years), but dietary habits have been shown to be rela-
tively stable over time.14–16 Based on the 2015 Dutch
Dietary guidelines and additional information from the
Netherlands Nutrition Center and Dutch food consump-
tions surveys, adherence to 14 components was assessed,
scored as yes (adherence) or no (no adherence): vegeta-
bles (≥200 g/day), fruit (≥200 g/day), whole grain prod-
ucts (≥90 g/day), ratio wholegrains:total grains (≥50%),
legumes (≥135 g/week), nuts (≥15 g/day), dairy (≥350 g/
day), fish (≥100 g/week), tea (≥450 mL/day), ratio unsat-
urated fats and oils:total fats (≥50%), red and processed
meat (≤300 g/week), sugar-containing beverages
(≤150 mL/day), alcohol (≤10 g/day) and salt (≤6 g/day).
Diet quality score was calculated as sum-score of the
adherence to the individual components (0–14), in which
a higher score represents a healthier diet.13,17
Polyneuropathy screening
Polyneuropathy screening consisted of a symptoms ques-
tionnaire, neurological examination of the legs, NCS of
the peroneal and sural nerves, and a review of medical
records.18 The questionnaire included questions concern-
ing bilaterally tingling or burning sensations, cotton-wool
feeling, muscle cramps, muscle pain not related to exer-
cise, stabbing pain, weakness, numbness, tightness and
allodynia of the feet or legs during the last 3 months.
Answers could be never, sometimes or (almost) continu-
ously. They were also asked if they were ever diagnosed
with polyneuropathy. Neurological examination consisted
of a bilateral examination of the legs including several
sensory tests, assessment of tendon reflexes and muscle
strength of the feet. Sensory tests included vibration sense
using a Rydel–Seiffer tuning fork at the hallux of both
feet, and superficial pain sensation using a disposable
wooden pin starting with stimulation at the knee and
ascending to the big toe. Ankle and knee tendon reflexes
were assessed in sitting position. Muscle strength of the
anterior tibial muscles was measured in lying position
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and participants were also asked to stand on their heels,
using balance support if needed. NCS were performed
with a NicoletTM Viking Quest (Natus Medical Incorpo-
rated, San Carlos, CA). The peroneal nerve was measured
unilaterally and the sural nerve bilaterally, according to a
predefined protocol.18 Both sensory and motor action
potential amplitudes were measured from baseline to
peak. Distal peroneal nerve compound muscle action
potential amplitude <1.1 mV and sural SNAP amplitude
<4.0 µV were considered abnormal, in accordance with
the cut-off values of our local hospital and literature.19,20
The highest of both sural SNAP amplitudes was used for
analyses.
All participants were individually discussed in an expert
panel. The panel was led by a neuromuscular specialist
(P. D.) and included a neurophysiology specialist (J. D.)
and two physicians trained in epidemiology (N. T. and R.
H.) with a special interest in neuromuscular diseases.
Information from the three components of the polyneu-
ropathy screening was used to categorize participants into
“no”, “possible”, “probable”, or “definite” chronic axonal
polyneuropathy, based on their level of abnormalities of
the components of the screening. Each component of the
screening was evaluated separately before establishing the
overall conclusion. Participants were discussed until una-
nimity was reached. Afterwards, their medical records
were reviewed for a diagnosis of polyneuropathy. A diag-
nosis by a neurologist after extensive neurological work-
up, irrespective of the cause, was considered superior to
our screening and participants were, if needed, (re)classi-
fied. Participants with missing data in more than one
component were exluded.18 For this study, participants
were divided in two groups: those having definite chronic
axonal polyneuropathy or not (no, possible and probable
combined).
Assessment of covariates
Covariates were measured during the home interviews by
trained interviewers or during the following visit to the
research center. Covariate assessment from the same
examination round as the dietary data was used. Blood
pressure was measured at the research center in sitting
position on the right arm and the average of two mea-
surements was used. Body mass index was calculated as
[(body weight in kilograms)/(length in meters)2]. Serum
cholesterol (mmol/L) was acquired by an automated
enzymatic procedure (Roche Hitachi 917 and Roche
Modular P800, Roche Diagnostics, Indianapolis, USA).
Serum creatinine levels were determined using an enzy-
matic assay method,21 and used to calculated the esti-
mated glomerular filtration rate (eGFR).22 Diabetes
mellitus type 2 was diagnosed if fasting blood glucose
≥7.0 mmol/L and/or use of antidiabetic drugs and/or pre-
vious diagnosis after review of the medical records. Infor-
mation about the use of antidiabetic and/or
antihypertensive drugs were obtained by interview and
pharmacy records.23 Smoking was categorized as never,
past, or current smoking. Education level was categorized
according to the UNESCO classification in four groups
ranging from low (primary education) to high (higher
vocational education or university). To maximize our sta-
tistical power, missing data on covariates was imputed
using fivefold multiple imputation, based on determinant,
outcome, and covariates. The percentages of missing val-
ues in covariates ranged from 0.3% to 1.9%.
Data analysis
Logistic regression was used to investigate the association
between diet quality and chronic axonal polyneuropathy.
Next, we used linear regression to determine the associa-
tion between diet quality and sural SNAP amplitude in
participants without definite polyneuropathy to investi-
gate a possible relation with subclinical nerve damage.
Additionally, logistic and linear regressions were also per-
formed with dietary intake data on a continuous (g/day)
instead of dichotomized scale (adherence yes/no). Sensi-
tivity analysis was performed comparing participants with
no versus definite polyneuropathy to rule out any possible
misclassification into either group of persons with proba-
ble polyneuropathy. Furthermore, we stratified by sex,
diabetes mellitus and alcohol intake (≤10 g/day), chosen
based on literature and biological plausibility, to explore
effect modification. All models were adjusted for age, sex,
time between determinant assessment and polyneuropathy
screening, body mass index, smoking status, blood pres-
sure, use of anti-hypertensive drugs, total cholesterol,
education level, eGFR, and diabetes mellitus.
Analyses were performed with IBM SPSS Statistics, ver-
sion 25. To correct for multiple testing we used the Sidak
correction that is based on the correlations between the
investigated food components.24 Using R statistical soft-
ware version 3.6.0, we computed the number of effective
tests (Meff = 13.61) and set the new alpha level for two-
tailed tests on P < 0.004.
Data availability
Data can be obtained on request. Requests should be
directed toward the management team of the Rotterdam
Study (secretariat.epi@erasmusmc.nl), which has a proto-
col for approving data requests. Because of restrictions
based on privacy regulations and informed consent of the
participants, data cannot be made freely available in a
public repository.
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RESULTS
We included 1650 participants of which 99 had definite
polyneuropathy (Table 1). Median age was 69.1 years (in-
terquartile range 58.8–73.8). Diabetes mellitus was present
in 30.3% of the participants with polyneuropathy and in
only 11.9% of the participants without polyneuropathy.
Participants without polyneuropathy were more often
current smokers (15.0%) compared to participants with
definite polyneuropathy (4.0%) while participants with
definite polyneuropathy were more often past smokers
(61.6% vs. 52.9%). Systolic and diastolic blood pressures
were comparable between groups, but the participants
with definite polyneuropathy more often used antihyper-
tensive drugs (56.6% vs. 36.4%).
Overall diet quality was not associated with the pres-
ence of chronic axonal polyneuropathy (odds ratio [OR]
0.99, 95% confidence interval [CI] 0.88; 1.12, P = 0.842),
and also not with the sural SNAP amplitude in partici-
pants without definite polyneuropathy (b = 0.01, 95% CI
0.14; 0.15, P = 0.993) (Table 2). Although not surviving
multiple testing, investigating individual components of
the dietary guidelines showed an association between
adhering to the advised amount of salt intake (≤6 g/day)
and a lower risk of having polyneuropathy (OR 0.55,
95% CI 0.35; 0.86, P = 0.008) (Table 2). Although not
Table 1. Characteristics of the overall study population, and stratified for participants with definite and without polyneuropathy (no, possible and
probable polyneuropathy).
Total population
N = 1650
Definite polyneuropathy
N = 99
Without polyneuropathy
N = 1551
Female 894 (54.2) 46 (46.5) 848 (54.7)
Age, years, median (IQR) 69.1 (58.8–73.8) 73.7 (68.8–77.4) 68.8 (58.4–73.5)
Education
Primary 92 (5.6) 5 (5.1) 87 (5.6)
Low-intermediate 576 (34.8) 46 (46.5) 529 (34.1)
Intermediate 557 (33.8) 28 (28.3) 529 (34.1)
High 426 (25.8) 20 (20.2) 406 (26.2)
Smoking status
Never 532 (32.3) 34 (34.3) 499 (32.2)
Past 881 (53.4) 61 (61.6) 820 (52.9)
Current 236 (14.3) 4 (4.0) 232 (15.0)
Systolic blood pressure, mmHg 144.0 (21.8) 146.8 (17.2) 143.8 (22.0)
Diastolic blood pressure, mmHg 84.7 (10.9) 83.9 (10.2) 84.7 (10.9)
Use of anti-hypertensive drugs 620 (37.6) 56 (56.6) 564 (36.4)
Diabetes mellitus 215 (13.0) 30 (30.3) 185 (11.9)
Body mass index, kg/m2 27.1 (3.9) 28.0 (4.2) 27.1 (3.8)
Cholesterol, mmol/L 5.4 (1.1) 5.2 (1.1) 5.5 (1.1)
eGFR, ml/min per 1.73 m2 78.7 (14.9) 76.4 (13.6) 78.8 (13.9)
Diet quality score 7.0 (1.9) 6.9 (1.6) 7.0 (1.9)
1 1 (0.1) 0 1 (0.1)
2 10 (0.6) 0 10 (0.6)
3 30 (1.8) 0 30 (1.9)
4 106 (6.4) 6 (6.1) 100 (6.4)
5 218 (13.2) 12 (12.1) 206 (13.3)
6 306 (18.5) 23 (23.2) 283 (18.2)
7 343 (20.8) 24 (24.2) 319 (20.6)
8 298 (18.1) 19 (19.2) 279 (18.0)
9 189 (11.5) 10 (10.1) 179 (11.5)
10 108 (6.5) 3 (3.0) 105 (6.8)
11 30 (1.8) 1 (1.0) 29 (1.9)
12 8 (0.5) 1 (1.0) 7 (0.5)
13 3 (0.2) 0 3 (0.2)
Sural SNAP amplitude, µV, median (IQR)1 7.0 (4.0–11.0) 0.0 (0.0–3.0) 8.0 (5.0–11.0)
Continuous data are in mean (SD) unless otherwise specified in the table. Categorical data are in number (%). Percentages do not all add up to
100% due to rounding. Diet quality score is a sum score of adherence (yes/no) to the components of the 2015 Dutch dietary guideline, ranging
from 0 to 14. IQR, interquartile range; eGFR, estimated glomerular filtration rate; SNAP, sensory nerve action potential.
1Available in 1272 participants.
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statistically significant, a similar trend was present on the
continuous scale where each g/day increase of salt was
associated with a higher risk of chronic axonal polyneu-
ropathy (OR 1.10, 95% CI 0.99; 1.22, P = 0.071)
(Table 3). No significant association between salt intake
and sural SNAP amplitude was found. Other individual
components of the dietary guidelines, both dichotomized
and continuously, also did not show an association with
diet quality (Tables 2 and 3).
The sensitivity analysis in participants with no or defi-
nite polyneuropathy showed similar results for diet qual-
ity (OR 0.99, 95% CI 0.88–1.13, P = 0.916) and the
individual components of the dietary guidelines (data not
shown). The results for the association between salt intake
and polyneuropathy were slightly strengthened (OR 0.51,
95% CI 0.32–0.82, P = 0.005). There was no effect modi-
fication by sex, diabetes mellitus, or alcohol use (data not
shown).
DISCUSSION
We found no association between diet quality and the
presence of chronic axonal polyneuropathy. Furthermore,
no association was found between diet quality and sural
SNAP amplitude in participants without polyneuropathy.
Diet is known to be an important modifiable risk fac-
tor for chronic diseases, such as diabetes and cardiovascu-
lar diseases, and for vitamin deficiencies and metabolic
syndrome.7,9,10,25 Metabolic syndrome is in turn linked
with chronic axonal polyneuropathy.26 Therefore, we
hypothesized that diet would be associated with chronic
Table 2. Association between diet quality and presence of chronic
axonal polyneuropathy in all participants (A) and between diet quality
and sural SNAP amplitude in participants without polyneuropathy (B).
A
N = 1650
Chronic axonal polyneuropathy
Odds ratio 95% CI P-value*
Diet quality score, per point
increase
0.99 0.88; 1.12 0.842
Adherence to dietary guideline, yes versus no
Vegetables (≥200 g/day) 1.23 0.79; 1.91 0.354
Fruit (≥200 g/day) 0.95 0.61; 1.49 0.832
Whole grains (≥90 g/day) 1.15 0.73; 1.80 0.552
Whole grains (as 50% of
total grains)
1.76 0.92; 3.34 0.086
Legumes
(≥135 g/week)
0.87 0.54; 1.41 0.580
Nuts (≥15 g/day) 1.34 0.81; 2.21 0.261
Dairy products
(≥350 g/day)
1.02 0.66; 1.58 0.918
Fish (≥100 g/week) 1.18 0.77; 1.81 0.459
Tea (≥450 mL/day) 1.19 0.43; 2.63 0.673
Healthy fat (as 50% of
total fats)
0.77 0.49; 1.19 0.238
Red meat (<300 g/week) 0.78 0.45; 1.34 0.364
Sugar containing
beverage
(≤150 mL/day)
0.84 0.49; 1.46 0.543
Alcohol (≤10 g/day) 1.00 0.63; 1.57 0.985
Salt (≤6 g/day) 0.55 0.35; 0.86 0.008
B
N = 1202
Sural SNAP amplitude (µV)
Difference1 95% CI
P-
value*
Diet quality score, per point
increase
0.01 0.14; 0.15 0.993
Adherence to dietary guideline, yes versus no
Vegetables (≥200 g/day) 0.30 0.24; 0.84 0.279
Fruit (≥200 g/day) 0.16 0.72; 0.40 0.573
Whole grains
(≥90 g/day)
0.29 0.85; 0.28 0.321
Whole grains (as 50% of
total grains)
0.31 0.37; 0.99 0.379
Legumes (≥135 g/week) 0.29 0.88; 0.30 0.333
Nuts (≥15 g/day) 0.56 0.08; 1.20 0.085
Dairy products
(≥350 g/day)
0.17 0.71; 0.37 0.531
Fish (≥100 g/week) 0.39 0.15; 0.92 0.158
Tea (≥450 mL/day) 0.32 0.73; 1.37 0.548
Healthy fat (as 50% of
total fats)
0.18 0.39; 0.75 0.532
Red meat (<300 g/week) 0.22 0.86; 0.42 0.508
(Continued)
Table 2. Continued.
B
N = 1202
Sural SNAP amplitude (µV)
Difference1 95% CI
P-
value*
Sugar containing beverage
(≤150 mL/day)
0.16 0.85; 0.52 0.641
Alcohol (≤10 g/day) 0.59 1.15; 0.03 0.038
Salt (≤6 g/day) 0.13 0.44; 0.70 0.659
Results are adjusted for age, sex, time between covariate assessment
and polyneuropathy screening, body mass index, smoking status, sys-
tolic and diastolic blood pressure, use of antihypertensive drugs, total
cholesterol, education level, eGFR and diabetes mellitus. Diet quality
score (range 0–14) is a sum score of adherence (yes/no) to the com-
ponents of the 2015 Dutch dietary guideline. SNAP, sensory nerve
action potential; CI, confidence interval.
1Adjusted mean difference for 1 unit increase.
*Significance level of P < 0.004 due to Sidak correction for multiple
testing.
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axonal polyneuropathy, but we could not confirm this in
our study. In line with our findings, a previous study on
intake of nutrients and CIAP also failed to show an asso-
ciation.11
Despite the strong hypothesis there are a few explana-
tions why diet was not associated with chronic axonal
polyneuropathy in our study. First, it is possible that
polyneuropathy shares a strong genetic link with diabetes
and metabolic syndrome, which consequently clouds any
association with more subtle nongenetic influences, such
as diet. Second, we might have inadvertently attenuated
any effect by adjustment for factors that are affected by
metabolic syndrome and such factor might be mediators
of the association between diet and polyneuropathy.
However, a model without such adjustment also did not
show any association, rendering this explanation less
likely. Finally, given the small effect size, a lack of power
cannot be ruled out.
Another question remains, why we did not find an
association with alcohol intake, an established risk factor
for polyneuropathy.27,28 Misclassification of alcohol intake
due to underreporting is expected to be more severe than
of diet in general. Moreover, most data on the link with
polyneuropathy come from studies on alcohol abuse,
whereas in our study most people had moderate alcohol
intake. Furthermore, the group abstainers is known to be
a difficult group to categorize in observational studies, as
both former and never drinkers together form this group
and might differ systematically from drinkers in ways that
are also related to disease but may be difficult to measure
and adjust for.29
We observed a nominal association for salt intake,
which points toward a role for a single nutrient as
opposed to overall diet. This association between adher-
ence to the advised amount of salt intake and the preva-
lence of chronic axonal polyneuropathy was present
irrespective of other risk factors. Even though this associ-
ation requires further replication, we speculate on possi-
ble mechanisms. An obvious link is hypertension, which
may damage the nerves via two ways. First, by damaging
the walls of small epi- and endoneural blood vessels and
second, by aggravating other components of the meta-
bolic syndrome.30–32
The major strength of this study is the use of compre-
hensive, validated FFQ that were converted into diet qual-
ity based on adherence to the dietary guidelines. By using
diet quality, instead of studying individual nutrients, it is
easy to translate findings to the general public. Moreover,
it takes potential interactions between nutrients into
account and it is less prone to measurement error than
an approach with single nutrients. Other strengths of this
study are the cohort design because these studies are less
prone to bias since the exposure is prospectively collected
Table 3. Association of individual diet components and presence of
chronic axonal polyneuropathy in all participants (A) and amplitude of
the sural SNAP amplitude in participants without polyneuropathy (B).
A
N = 1650
Chronic axonal polyneuropathy
Odds ratio 95% CI P-value*
Vegetables (per 100 g/day) 1.03 0.91; 1.16 0.677
Fruit (per 100 g/day) 0.96 0.89; 1.03 0.959
Whole grains (per 10 g/day) 1.01 0.98; 1.04 0.757
Whole grains (per 10% of total
grain)
1.04 0.95; 1.14 0.377
Legumes (per 10 g/week) 0.98 0.89; 1.09 0.750
Nuts (per 10 g/day) 1.09 0.98; 1.23 0.096
Dairy products (per 100 g/day) 1.06 0.97; 1.15 0.232
Fish (per 10 g/week) 1.03 0.94; 1.14 0.534
Tea (per 50 g/day) 1.05 1.00; 1.10 0.065
Healthy fat (per 10% of total
fats)
0.95 0.87; 1.04 0.257
Red meat (per 10 g/week) 1.04 0.99; 1.09 0.141
Sugar containing beverages
(per 100 mL/day)
1.16 0.94; 1.43 0.157
Alcohol (per 10 g/day) 1.04 0.88; 1.23 0.661
Salt (per 1 g/day) 1.10 0.99; 1.22 0.071
B
N = 1202
Sural SNAP amplitude (µV)
Difference1 95% CI P-value*
Vegetables (per 100 g/day) 0.02 0.13; 0.17 0.790
Fruit (per 100 g/day) 0.08 0.17; 0.01 0.075
Whole grains (per 10 g/day) 0.01 0.04; 0.03 0.749
Whole grains (per 10% of
total grain)
0.03 0.14; 0.08 0.603
Legumes (per 10 g/week) 0.07 0.20; 0.06 0.290
Nuts (per 10 g/day) 0.08 0.09; 0.24 0.375
Dairy products (per
100 g/day)
0.05 0.16; 0.06 0.368
Fish (per 10 g/week) 0.06 0.06; 0.19 0.322
Tea (per 50 g/day) 0.06 0.01; 0.13 0.071
Healthy fat (per 10% of total
fats)
0.05 0.06; 0.16 0.402
Red meat (per 10 g/week) 0.05 0.11; 0.01 0.112
Sugar containing beverages
(per 100 mL/day)
0.16 0.12; 0.44 0.257
Alcohol (per 10 g/day) 0.15 0.06; 0.36 0.173
Salt (per 1 g/day) 0.07 0.20; 0.06 0.309
Results are adjusted for age, sex, time between covariate assessment
and polyneuropathy screening, body mass index, smoking status, sys-
tolic and diastolic blood pressure, use of antihypertensive drugs, total
cholesterol, education level, eGFR and diabetes mellitus. Diet quality
score (range 0–14) is a sum score of adherence (yes/no) to the com-
ponents of the 2015 Dutch dietary guideline. SNAP, sensory nerve
action potential; CI, confidence interval.
1Adjusted mean difference for 1 unit increase.
*Significance level of P < 0.004 due to Sidak correction for multiple
testing.
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independent of the outcome of interest. Furthermore, we
adjusted for several important possible confounders and
investigated whether effect modification was present by
stratification. Additionally, as persons that adherence to
one component of the dietary guidelines are more likely
to adhere to other components, we used the Sidak correc-
tion to correct for multiple testing and to account for
correlations between the food components.14–16,24 A limi-
tation of our study is the time difference between mea-
surements that might have led to misclassification and
selective survival, which can both lead to dilution of the
effect. Yet, these methodological influences are likely min-
imal, as the time difference was relatively short and diet-
ary patterns and other lifestyle factors are expected to
remain relatively constant over time.14–16 Furthermore,
we have to take into account that assessment of dietary
intake using questionnaires is prone to measurement
error. Especially dietary sodium intake is hard to estimate
and further studies are warranted before conclusions can
be drawn on a role for salt intake in polyneuropathy.
In conclusion, we showed in this population-based
study that diet quality is not associated with the presence
of chronic axonal polyneuropathy.
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